{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:37:24Z","timestamp":1771925844837,"version":"3.50.1"},"reference-count":51,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Personalized Medicine"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.2217\/17410541.3.4.391","type":"journal-article","created":{"date-parts":[[2006,12,15]],"date-time":"2006-12-15T11:11:31Z","timestamp":1166181091000},"page":"391-397","source":"Crossref","is-referenced-by-count":10,"title":["Legal Pressures and Incentives for Personalized Medicine"],"prefix":"10.1080","volume":"3","author":[{"given":"Gary E","family":"Marchant","sequence":"first","affiliation":[{"name":"Sandra Day O\u2018Connor College of Law, PO Box 877906, Tempe, AZ85287\u20137906, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Milligan","sequence":"additional","affiliation":[{"name":"Sandra Day O\u2018Connor College of Law, PO Box 877906, Tempe, AZ85287\u20137906, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Wilhelmi","sequence":"additional","affiliation":[{"name":"Sandra Day O\u2018Connor College of Law, PO Box 877906, Tempe, AZ85287\u20137906, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2006,12,15]]},"reference":[{"key":"e_1_3_1_2_1_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/047142613X.ch10","volume-title":"Pharmacogenomics: Social, Ethical, and Clinical Dimensions.","author":"Palmer LI","year":"2003","unstructured":"Palmer LI : Medical liability for pharmacogenomics. In:Pharmacogenomics: Social, Ethical, and Clinical Dimensions. Rothstein MA (Ed.), John Wiley & Sons, Hoboken, NJ, USA, 187\u2013206 (2003)."},{"key":"e_1_3_1_2_2_1","first-page":"117","article-title":"Liability issues in pharmacogenomics.","volume":"66","author":"Rothstein MA","year":"2005","unstructured":"Rothstein MA : Liability issues in pharmacogenomics.Louisiana Law Rev.66 , 117\u2013124 (2005).","journal-title":"Louisiana Law Rev."},{"key":"e_1_3_1_2_3_1","unstructured":"Hotchkiss A ErwayCE: Burden of failure-to-warn pharmaceutical defendants \u2013 heed this warning. For the Defense 13\u201317 (2006)."},{"key":"e_1_3_1_2_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500284"},{"key":"e_1_3_1_2_5_1","unstructured":"57 A.L.R. 5th 1 Construction and Application of the Learned-Intermediary Doctrine (1991)."},{"key":"e_1_3_1_2_6_1","unstructured":"Perez v Wyeth Laboratories 734 A. 2d 1245 (N.J. 1999)."},{"key":"e_1_3_1_2_7_1","unstructured":"Edwards v. Basel Pharmaceuticals 933 P.2d 298 (Okla. 1997)."},{"key":"e_1_3_1_2_8_1","unstructured":"Food and Drug Administration: Federal Register 71 3921\u20133997 (Jan. 24 2006)."},{"key":"e_1_3_1_2_9_1","unstructured":"Jackson V Pfizer Inc. 432 F.Supp.2d 964 (D.Neb. 2006)."},{"key":"e_1_3_1_2_10_1","unstructured":"American Law Institute: Restatement (Third) of Torts: Products Liability ."},{"key":"e_1_3_1_2_11_1","first-page":"76","article-title":"Rethinking conscious design liability for prescription drugs: the Restatement (Third) standard versus a negligence approach.","volume":"63","author":"Cupp RL","year":"1994","unstructured":"Cupp RL : Rethinking conscious design liability for prescription drugs: the Restatement (Third) standard versus a negligence approach.George Wash. L. Rev.63 , 76\u2013110 (1994).","journal-title":"George Wash. L. Rev."},{"key":"e_1_3_1_2_12_1","unstructured":"Freeman v. Hoffman-La Roche Inc . 618 N.W.2d 827 (Neb. 2000)."},{"key":"e_1_3_1_2_13_1","first-page":"547","article-title":"Twenty-first century toxicogenomics meets twentieth century mass tort precedent: is there a duty to warn of a hypothetical harm to an \u2018eggshell\u2018 gene?","volume":"42","author":"Redick TP","year":"2003","unstructured":"Redick TP : Twenty-first century toxicogenomics meets twentieth century mass tort precedent: is there a duty to warn of a hypothetical harm to an \u2018eggshell\u2018 gene?Washburn Law J.42 , 547\u2013574 (2003).","journal-title":"Washburn Law J."},{"key":"e_1_3_1_2_14_1","doi-asserted-by":"publisher","DOI":"10.1517\/phgs.5.3.319.29832"},{"key":"e_1_3_1_2_15_1","unstructured":"Nuffield Council on Bioethics: Pharmacogenetics : Ethical Issues Nuffield Council London UK (2003)."},{"key":"e_1_3_1_2_16_1","unstructured":"Adams v. G.D. Searle & Co. 576 So.2d 728 (Fla.Dist.Ct. App.) rev. denied 589 So.2d 290 (Fla. 1991)."},{"key":"e_1_3_1_2_17_1","unstructured":"Stitt v. Philip Morris Inc. 245 F.Supp.2d 686 (W.D. Pa. 2002)."},{"key":"e_1_3_1_2_18_1","unstructured":"Lachance v. American Home Products Corp. No. 01\u20130890-CV-W-ODS 2006 WL 89850 (W.D. Mo. Jan. 13 2006)."},{"key":"e_1_3_1_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/425760a"},{"key":"e_1_3_1_2_20_1","unstructured":"Cassidy v. SmithKline Beecham Amended Complaint Class Action 10 No. 99\u201310423 Court of Common Please Chester County PA USA."},{"key":"e_1_3_1_2_21_1","unstructured":"Okie S : Lyme disease vaccine\u2018s safety is questioned Wash. Post Apr. 8 2001 at A3."},{"key":"e_1_3_1_2_22_1","first-page":"661","volume-title":"Ann. Intern. Med.","author":"Thanassi WT, Schoen RT: The Lyme Disease vaccine: conception, development, and implementation","year":"2000","unstructured":"Thanassi WT, Schoen RT: The Lyme Disease vaccine: conception, development, and implementation . Ann. Intern. Med.132 , 661\u2013668 (2000)."},{"key":"e_1_3_1_2_23_1","first-page":"493","article-title":"ERISA right to sue: an Rx for healthcare that places form over substantive consumer rights.","volume":"31","author":"Nevers AH","year":"2001","unstructured":"Nevers AH : ERISA right to sue: an Rx for healthcare that places form over substantive consumer rights.New Mexico Law Rev.31 , 493\u2013537 (2001).","journal-title":"New Mexico Law Rev."},{"key":"e_1_3_1_2_24_1","first-page":"767","volume-title":"J. Health Polit. Policy Law","author":"Hammer PJ","year":"2001","unstructured":"Hammer PJ : Pegram v. Herdrich: On peritonitis, preemption, and the elusive goal of managed care accountability.J. Health Polit. Policy Law26 , 767\u2013787 (2001)."},{"key":"e_1_3_1_2_25_1","unstructured":"Pegram v. Herdrich 120 S. Ct. 2143 (2000)."},{"key":"e_1_3_1_2_26_1","unstructured":"Johnson SH Schwartz RL Greaney TL Stoltzfus Jost T: Health Law. 2nd edition. West Group Eagan MN USA \u00a77\u201312 (2000)."},{"key":"e_1_3_1_2_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/35056075"},{"key":"e_1_3_1_2_28_1","unstructured":"Molloy v Meier 679 N.W. 2d 711 (Minn. 2004)."},{"key":"e_1_3_1_2_29_1","unstructured":"Geler v Akawie 818 A. 2d 402 (N.J. App. 2003)."},{"key":"e_1_3_1_2_30_1","unstructured":"Paretta v Medical Offices for Human Reproduction 760 N.Y.S. 2d 639 (2003)."},{"key":"e_1_3_1_2_31_1","unstructured":"Becker v Schwartz 413 N.Y.S. 2d 865 (1978)."},{"key":"e_1_3_1_2_32_1","unstructured":"Schirmer v Mt. Auburn Obstetrics & Gynecologic Associates Inc. 802 N.E. 2d 723 (Ohio App. 2003)."},{"key":"e_1_3_1_2_33_1","unstructured":"Breyne v Potter 574 S.E. 2d 916 (Ga. App. 2002)."},{"key":"e_1_3_1_2_34_1","unstructured":"Didato v Strehler 554 S.E.2d 42 (Va. 2001)."},{"key":"e_1_3_1_2_35_1","unstructured":"Revised Arizona Jury Instructions (Civil) 3d Medical Malpractice 1."},{"key":"e_1_3_1_2_36_1","unstructured":"A.R.S. Section 12\u2013563."},{"key":"e_1_3_1_2_37_1","unstructured":"Barrett v. Samaritan Health Services Inc. 735 P.2d 460 463 (App.1987)."},{"key":"e_1_3_1_2_38_1","unstructured":"Geler v Akawie 818 A. 2d 402 (N.J. App. 2003)."},{"key":"e_1_3_1_2_39_1","unstructured":"Schirmer v Mt. Auburn Obstetrics & Gynecologic Associates Inc. 802 N.E. 2d 723 (Ohio App. 2003)."},{"key":"e_1_3_1_2_40_1","unstructured":"Duncan v. Scottsdale Medical Imaging Ltd. 70 P.3d 435 (Ariz. 2003)."},{"key":"e_1_3_1_2_41_1","unstructured":"Gouveia v Phillips 823 So. 2d 215 (Fla. App. 2002)."},{"key":"e_1_3_1_2_42_1","unstructured":"Furrow BR Johnson SH Schwartz RL Greaney TL Stoltzfus Jost T: Health Law. 2nd edition. West Group Eagan MN USA 313\u2013315 (2000)."},{"key":"e_1_3_1_2_43_1","unstructured":"Festa v. Greenberg 354 Pa. Super. 346 511 A.2d 1371 (1986)."},{"key":"e_1_3_1_2_44_1","unstructured":"Helling v Carey 519 P. 2d 981 (Wash. 1974)."},{"key":"e_1_3_1_2_45_1","doi-asserted-by":"crossref","unstructured":"Riedisser v. Nelson 534 P.2d 1052 (Ariz. 1975).","DOI":"10.5694\/j.1326-5377.1975.tb106045.x"},{"key":"e_1_3_1_2_46_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0098858800010510"},{"key":"e_1_3_1_2_47_1","first-page":"25","article-title":"The pharmacist\u2018s evolving intellectual duty to warn.","author":"Fern F","year":"2005","unstructured":"Fern F , BergmanJ: The pharmacist\u2018s evolving intellectual duty to warn.For the Defense25\u201329 (2005).","journal-title":"For the Defense"},{"key":"e_1_3_1_2_48_1","doi-asserted-by":"publisher","DOI":"10.1517\/phgs.4.3.321.22698"},{"issue":"1","key":"e_1_3_1_2_49_1","first-page":"115","article-title":"Human Genome Project and pharmacogenomics \u2013 implications for pharmacy.","volume":"40","author":"Carrico JM","year":"2000","unstructured":"Carrico JM : Human Genome Project and pharmacogenomics \u2013 implications for pharmacy.J. Am. Pharm. Assoc.40(1) , 115\u2013116 (2000).","journal-title":"J. Am. Pharm. Assoc."},{"key":"e_1_3_1_2_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/35056075"},{"key":"e_1_3_2_2_1","unstructured":"Adams CK UrquhartJE De Santos l: The duty to use pharmacogenetics and pharmacogenomics to reduce the risk of idiosyncratic drug-induced liver injury. Drug Recall Litigation Reporter March 2004. http:\/\/library.findlaw.com\/2004\/Feb\/27\/133310.html."}],"container-title":["Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/17410541.3.4.391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:48:56Z","timestamp":1715953736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/17410541.3.4.391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.2217\/17410541.3.4.391"],"URL":"https:\/\/doi.org\/10.2217\/17410541.3.4.391","relation":{},"ISSN":["1741-0541","1744-828X"],"issn-type":[{"value":"1741-0541","type":"print"},{"value":"1744-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}